- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
North Chicago Today
By the People, for the People
Hamilton Wealth LLC Invests $4.92 Million in AbbVie Inc.
Hedge fund adds to position in pharmaceutical company
Mar. 16, 2026 at 11:21am
Got story updates? Submit your updates here. ›
Hamilton Wealth LLC, a financial services firm, acquired a new position in AbbVie Inc. (NYSE:ABBV) during the third quarter of 2025, purchasing 21,229 shares of the company's stock valued at approximately $4.92 million. This investment represents 1.0% of Hamilton Wealth's portfolio, making AbbVie the 27th largest holding in the firm's investment strategy.
Why it matters
AbbVie is a major pharmaceutical company known for its blockbuster drugs like Humira. The company's stock has been a strong performer, and institutional investors like Hamilton Wealth are closely watching the company's pipeline and financial performance. This investment signals that Hamilton Wealth sees further upside potential in AbbVie's shares.
The details
According to a 13F filing with the SEC, Hamilton Wealth LLC acquired the 21,229 shares of AbbVie stock during the third quarter of 2025. The shares were valued at approximately $4.92 million, or an average price of $231.80 per share. This new position represents 1.0% of Hamilton Wealth's total investment portfolio.
- Hamilton Wealth LLC acquired the AbbVie shares during the third quarter of 2025.
The players
Hamilton Wealth LLC
A financial services firm that manages investments and wealth for clients.
AbbVie Inc.
A global biopharmaceutical company that develops and markets a variety of specialty medicines, including the blockbuster drug Humira.
The takeaway
Hamilton Wealth's investment in AbbVie reflects the pharmaceutical company's strong performance and the hedge fund's belief in its continued growth potential. As a major player in the drug industry, AbbVie's stock remains an attractive option for institutional investors seeking exposure to the healthcare sector.
